en
Scientific article
Review
English

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

Published inThe oncologist, vol. 15, no. 4, p. 390-404
Publication date2010
Abstract

The number of agents that are potentially effective in the adjuvant treatment of locally advanced resectable colon cancer is increasing. Consequently, it is important to ascertain which subgroups of patients will benefit from a specific treatment. Despite more than two decades of research into the molecular genetics of colon cancer, there is a lack of prognostic and predictive molecular biomarkers with proven utility in this setting. A secondary objective of the Pan European Trials in Adjuvant Colon Cancer-3 trial, which compared irinotecan in combination with 5-fluorouracil and leucovorin in the postoperative treatment of stage III and stage II colon cancer patients, was to undertake a translational research study to assess a panel of putative prognostic and predictive markers in a large colon cancer patient cohort. The Cancer and Leukemia Group B 89803 trial, in a similar design, also investigated the use of prognostic and predictive biomarkers in this setting. In this article, the authors, who are coinvestigators from these trials and performed similar investigations of biomarker discovery in the adjuvant treatment of colon cancer, review the current status of biomarker research in this field, drawing on their experiences and considering future strategies for biomarker discovery in the postgenomic era.

Keywords
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms/ genetics/pathology/therapy
  • Disease Progression
  • Genes, p53/genetics
  • Genomic Instability
  • Genomics
  • Humans
  • Microsatellite Instability
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Proto-Oncogene Proteins/genetics
  • Proto-Oncogene Proteins B-raf/genetics
  • Tumor Markers, Biological
  • Ras Proteins/genetics
Citation (ISO format)
TEJPAR, Sabine et al. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. In: The oncologist, 2010, vol. 15, n° 4, p. 390–404. doi: 10.1634/theoncologist.2009-0233
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal1083-7159
542views
0downloads

Technical informations

Creation05/23/2012 8:57:38 AM
First validation05/23/2012 8:57:38 AM
Update time03/14/2023 5:36:06 PM
Status update03/14/2023 5:36:05 PM
Last indexation02/12/2024 8:20:11 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack